Replies to post #807061 on NorthWest Biotherapeutics Inc (NWBO)

[seekinganswers]

WRONG.
CHM is where apps go to die. and... it doesn't need to be disclosed because it's internal and not officially rejected yet.
Also, your fearless CEO already said she wont release any info until a FINAL decision is made. That hasn't happened yet, she will likely appeal and drag you out for another 6 months.
PS it's not new or novel, it's due to a failed P III trial and an antiquated tech.
JMHO,... good luck.

[AllSheWrote]

if it was a referral for denial, it would need to be disclosed

False. And even if true, when has the CEO ever thought she needed to disclose anything? Remember the 2015 efficacy IA? When did we find out about that? Oh, right, in 2024.

[learningcurve2020]

Still waiting for anyone to dig up anything that might resemble what $consultants$ are allegedly telling her?

>>What is noteworthy, and I would say this is based on what our UK advisors have said to us, we don’t have firsthand knowledge, but our advisors have said that there are quite a number of other companies who are in the situation that we’re in and are very long into the application process, can be as much as two years like we are. It’s not just us. That is a comfort factor, and it was helpful to hear that from our advisors. I don’t have firsthand knowledge, but they’re experts and they see the landscape.